COVID-19 induced ARDS, and the use of galantamine to activate the cholinergic anti-inflammatory pathway.
作者信息
Ahmad Farrukh
机构信息
Saint Vincet Hospital, Worcester, MA, 01608, USA.
出版信息
Med Hypotheses. 2020 Dec;145:110331. doi: 10.1016/j.mehy.2020.110331. Epub 2020 Oct 6.
Abstract
摘要
相似文献
1
COVID-19 induced ARDS, and the use of galantamine to activate the cholinergic anti-inflammatory pathway.
Med Hypotheses. 2020 Dec;145:110331. doi: 10.1016/j.mehy.2020.110331. Epub 2020 Oct 6.
2
Activation of the Cholinergic Anti-Inflammatory Pathway as a Novel Therapeutic Strategy for COVID-19.
Front Immunol. 2021 Feb 8;11:595342. doi: 10.3389/fimmu.2020.595342. eCollection 2020.
3
Feasibility of Therapeutic Effects of the Cholinergic Anti-Inflammatory Pathway on COVID-19 Symptoms.
J Neuroimmune Pharmacol. 2020 Jun;15(2):165-166. doi: 10.1007/s11481-020-09919-6. Epub 2020 May 7.
4
Covid-19, Angiogenesis, and ARDS Endotypes.
N Engl J Med. 2020 Jul 9;383(2):182-183. doi: 10.1056/NEJMe2018629. Epub 2020 May 21.
5
Therapeutic Potential of Mesenchymal Stem Cells and Their Secretome in the Treatment of SARS-CoV-2-Induced Acute Respiratory Distress Syndrome.
Anal Cell Pathol (Amst). 2020 Nov 20;2020:1939768. doi: 10.1155/2020/1939768. eCollection 2020.
6
Severe Covid-19 disease: rather AVDS than ARDS?
Crit Care. 2020 Jun 11;24(1):327. doi: 10.1186/s13054-020-02972-w.
7
Simultaneous ventilation of two simulated ARDS patients in COVID-19 pandemic.
Crit Care. 2020 May 11;24(1):214. doi: 10.1186/s13054-020-02940-4.
8
[Therapy of coronavirus disease 2019 induced acute respiratory distress syndrome is different from traditional acute respiratory distress syndrome].
Zhonghua Shao Shang Za Zhi. 2020 May 20;36(5):330-333. doi: 10.3760/cma.j.cn501120-20200407-00214.
9
VV-ECMO usage in ARDS due to COVID-19: Clinical, practical and ethical considerations.
J Clin Anesth. 2020 Oct;65:109893. doi: 10.1016/j.jclinane.2020.109893. Epub 2020 May 20.
10
Rho kinase inhibitors for SARS-CoV-2 induced acute respiratory distress syndrome: Support from Bartter's and Gitelman's syndrome patients.
Pharmacol Res. 2020 Aug;158:104903. doi: 10.1016/j.phrs.2020.104903. Epub 2020 May 13.
引用本文的文献
1
Regulation of Inflammation by IRAK-M Pathway Can Be Associated with nAchRalpha7 Activation and COVID-19.
Mol Neurobiol. 2024 Feb;61(2):581-592. doi: 10.1007/s12035-023-03567-6. Epub 2023 Aug 29.
2
Medicinal nicotine in COVID-19 acute respiratory distress syndrome, the new corticosteroid.
World J Crit Care Med. 2022 Jul 9;11(4):228-235. doi: 10.5492/wjccm.v11.i4.228.
3
Therapeutic implications of SARS-CoV-2 dysregulation of the gut-brain-lung axis.
World J Gastroenterol. 2021 Aug 7;27(29):4763-4783. doi: 10.3748/wjg.v27.i29.4763.
4
Nicotinic Acetylcholine Receptor Involvement in Inflammatory Bowel Disease and Interactions with Gut Microbiota.
Int J Environ Res Public Health. 2021 Jan 29;18(3):1189. doi: 10.3390/ijerph18031189.
5
The evolving obesity challenge: targeting the vagus nerve and the inflammatory reflex in the response.
Pharmacol Ther. 2021 Jun;222:107794. doi: 10.1016/j.pharmthera.2020.107794. Epub 2020 Dec 10.
Zotero 插件